These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23388124)

  • 1. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history.
    Hazard FK; Longacre TA
    Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
    Köbel M; Kalloger SE; Huntsman DG; Santos JL; Swenerton KD; Seidman JD; Gilks CB;
    Int J Gynecol Pathol; 2010 May; 29(3):203-11. PubMed ID: 20407318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-malignant potential epithelial tumors of the ovary: a clinicopathological study.
    Hassan E; Koumantaki Y; Stefanaki K; Matalliotakis I; Koumantakis E
    Eur J Gynaecol Oncol; 1998; 19(2):170-2. PubMed ID: 9611060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ovarian tumors express gamma-glutamyl transpeptidase.
    Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
    Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of radiotherapy for state I ovarian carcinoma].
    Sheng X; Sun J; Zhou C
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
    Cuff J; Longacre TA
    Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of the epithelial ovarian cancer at the West African Cancer Center of Dakar].
    Dem A; Dieng MM; Ka S; Gaye PM; Diouf D; Gaye-Fall MC
    Bull Cancer; 2013 Feb; 100(2):155-60. PubMed ID: 23407147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. My approach to and thoughts on the typing of ovarian carcinomas.
    McCluggage WG
    J Clin Pathol; 2008 Feb; 61(2):152-63. PubMed ID: 17704261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common epithelial tumors of the ovary: proliferating and of low malignant potential.
    Ulbright TM; Roth LM
    Semin Diagn Pathol; 1985 Feb; 2(1):2-15. PubMed ID: 2832916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative activity and p53 over-expression of ovarian epithelial tumors.
    Kuwata T; Kitagawa M; Takemura T; Hirokawa K
    Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial ovarian tumors in children: a retrospective analysis.
    Morowitz M; Huff D; von Allmen D
    J Pediatr Surg; 2003 Mar; 38(3):331-5; discussion 331-5. PubMed ID: 12632344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.